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Stefano Pernigo, Atsushi Fukuzawa, Alessandro Pandini
and Mark Holtend: The C-terminus of the giant muscle protein titin
s obscurin at the myofibrillar periphery and obscurin-
-1 at the myofibrillar core. The crystal structure of the titin:
curin complex reveals a conserved zipper module and an
onventional topology for the obscurin immunoglobulin
ain. The titin:obscurin/obscurin-like-1 complexes appear
fectly poised as discriminatory structural elements poten-
y directing the binding of additional partners.M10 is the most C-terminal immunoglobulin (Ig)
domain of the giant protein titin and a frequent target
of disease-linked mutations. Currently, it is the only
known muscle Ig domain able to interact with two
alternative ligands—obscurin and obscurin-like-1
(Obsl1)—in different sarcomeric subregions.
Obscurin and Obsl1 use their homologous N-terminal
Ig domain (O1 in obscurin and OL1 in Obsl1) to bind
M10 in amutually exclusivemanner. We present here
theX-ray structure of the human titin:obscurinM10:O1
complex extending our previouswork on theM10:OL1
interaction. Similar to M10:OL1, the M10:O1 complex
displays a chevron-shaped antiparallel Ig–Ig architec-
ture held together by a conservedmolecular interface,
which we validated by isothermal titration calorimetry
and sorting experiments in neonatal rat cardiomyo-
cytes. O1, although structurally related to OL1 and
M10, both members of the intermediate set (I-set) Ig
family, presents an intriguing switch of its βA′ strand.
This leads to structural differences between the
complexes, particularly for the “open side” of the
chevron-shaped assembly. A bioinformatics analysis
reveals that the βA′-switch observed for O1 is rare and
that it is involved in mediating protein–protein interac-
tions. Molecular dynamics simulations also suggest
that this topological alteration substantially increases
local flexibility compared to the conventional I-set Ig
domains. The O1/OL1 Ig domains are candidate
discriminatory structural modules potentially directing
the binding of specific additional partners at the
M-band. Cellular sorting experiments in neonatal rat
cardiomyocytes are consistent with the view that theJ. Mol. Biol. (2015) 427, 718–736
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© 2014 Published by Elsevier Ltd.Introduction
The assembly and maintenance of functional sarco-
meres in cardiac and skeletal muscles rely on the
establishment of complex multiprotein networks regu-
lated both spatially and temporally [1]. The giant protein
titin spanning half of the sarcomere length offers a
docking platform for several binding partners. At the
M-band, theC-terminus of titin is engaged in a complex
with the 800-kDa protein obscurin or, alternatively, its
smaller 130- to 230-kDa obscurin-like-1 (Obsl1) ana-
logue (Fig. 1a) [2]. Obscurin and Obsl1, in turn, interact
with the myosin cross-linking protein myomesin, a
critical component of M-band structural integrity [2].
Titin's C-terminus is important for muscle function as
multiple mutations mapping to this region cause
hereditary myopathies such as tibial muscular dystro-
phy and limb girdle muscular dystrophy 2J [3,4].
Cellular roles for obscurin and Obsl1 are slowly
emerging. Like titin and other sarcomeric proteins,
obscurin and Obsl1 share a common immunoglobulin
(Ig)-rich modular structure, which, in the case of
obscurin, is more extended, featuring additional signal-
ing and protein-binding domains absent in Obsl1
(Fig. 1a) [2]. The presence of a nonmodular C-terminus
able to interact with sAnk1.5 (small ankyrin-1 isoform5)
and Ank2 (ankyrin-2) led to the suggestion that
obscurin plays a role in establishing the sarcomere–
sarcoplasmic reticulum (SR) connection [5,6]. Experi-
ments in Obscn−/− mice support this view. Ablation of
the Obscn gene results in changes in longitudinal SR
architecture with alterations in several SR or SR-asso-
ciated proteins, such asAnk2 andβ-spectrin, aswell as
disruption of sAnk1.5 expression and localization [7,8].
Similarly, depletion of obscurin in zebrafish led to
disturbances in the extracellular matrix organization
during skeletalmuscle development [9]. Signaling roles
for obscurin, in addition to structural ones, are
suggested by the presence of anSH3–DH–PHdomain
tandem predicted to act as guanine nucleotide GDP–
GTP exchange factors, as well as up to two kinase
domains present in some of its isoforms [10]. From a
pathological viewpoint, OBSCN polymorphisms in
humans have been linked to the development of
hypertrophic cardiomyopathy [11] as well as to aspirin
hypersensitivity in asthmatics [12]. The latter effect can
be rationalized considering the interplay between
airway remodeling and intracellular Ca2+ regulation
by the SR of the airway smooth muscle cells; however,
functional evidence for the pathogenicity of these
variants at the biochemical level is lacking.
Obsl1 lacks the Ank-binding sites that link the
obscurin C-terminus to the SR. In keeping with this,Obsl1 and obscurin exhibit alternative subcellular
localization in the muscle [2]. While obscurin is found
at the myofibril periphery, Obsl1 localizes in the
myofibril core where it likely acts as an adaptor
molecule. Recently, mutations in Obsl1 have been
linked to the rare hereditary growth retardation 3-M
syndrome [13] with a role for Obsl1 in the mainte-
nance of cullin-7 levels [14] and regulation of
insulin-like growth factor binding proteins [13].
Pathogenic cullin-7 mutations are known as the
primary cause of 3-M syndrome [15]. A recent
account further strengthens the link between Obsl1
and cullin-7 by showing that these proteins physi-
cally interact in neurons and that Obsl1 plays a role
in Golgi morphogenesis and dendrite elaboration
[16]. Overall, in spite of similar modular architec-
tures, obscurin and Obsl1 appear to have rather
distinct biological functions.
At the molecular level, obscurin and Obsl1 are
targeted to themuscleM-band by an interaction of their
first Ig domain (hereafter O1 and OL1, respectively)
with the most C-terminal titin's Ig domain (M10) as well
as by an interaction of their third Ig domain (O3 and
OL3) with myomesin [2] (Fig. 1a). The atomic basis for
the M10:OL1 interaction has recently been elucidated
by us and others [17,18]. The complex displays a novel
chevron-shaped architecture with an antiparallel ar-
rangement of its Ig protomers in agreement with the
orientation expected in the sarcomere. We have
extended our previous structural work on M10:OL1
and present here the X-ray structure of the human titin:
obscurin M10:O1 complex in two alternative crystal
forms. In spite of a largely conserved binding interface,
an uncommon topological variation in the O1 module
leads to structural differences between the M10:O1
and M10:OL1 complexes, particularly for the “open
side” of their “chevron-shaped” architecture. The O1
and OL1 modules appear perfectly poised as discrim-
inatory structural elements potentially involved in the
binding of additional specific partners.Results and Discussion
Structure solution of the M10:O1 complex
The initial design of the M10:O1 constructs for
crystallographic studies was guided by the titin:Obsl1
M10:OL1 structure [17]. In vitro reconstituted M101–99:
O17–109 (M101–99 corresponds to titin34252–34350;
O17–109 is Obscurin7–109) failed however to crystal-
lize. Partial degradation of O17–109 appeared a
Fig. 1. Titin's C-terminus interacts with obscurin/Obsl1 N-terminus. (a) Cartoon representation of the modular organization of M-band titin and its obscurin and Obsl1
binding partners. The C-terminal M10 Ig domain of titin (shown in orange) interacts with the first Ig domain of obscurin (O1 in blue) and the first Ig domain of Obsl1 (OL1 in
green) in a mutually exclusive fashion in different sarcomeric subregions. (b) SEC profile and SDS-PAGE analysis of the in vitro reconstituted M10:O1 complex.
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Table 1. Data collection and refinement statistics
Data set M10:O1
(trigonal)
M10:O1 (orthorhombic)
Data collection
Beamline I24 (DLS) I24 (DLS)
Wavelength (Å) 0.9778 0.9686
Resolution range (Å) 40.0–3.30 35.70–1.95
Highest-resolution bin (Å) (3.48–3.30) (2.00–1.95)
Space group P3221 P212121
Cell dimensions
a, b, c (Å) 201.55, 201.55, 183.96 40.94, 66.88, 72.93
α, β, γ (°) 90, 90, 120 90, 90, 90
Unique reflections 64,369 (9315) 15,005 (1053)
Overall redundancy 3.0 (3.0) 3.3 (3.1)
Completeness (%) 98.9 (99.2) 99.0 (98.5)
Rmerge (%) 21.5 (52.4) 5.3 (62.2)
〈I/σ(I)〉 4.3 (2.2) 12.8 (2.0)
Refinement
PDB code 4UOW 4C4K
Rfactor (%)/Rfree (%) 17.7/21.0 17.1/21.0
No. of non-H atoms
Protein 25,784 1456
Heterogen (nonwater) 9 52
Water 0 114
rms bond lengths (Å) 0.008 0.010
rms bond angles (°) 1.00 1.12
721Crystal Structure of the Titin:Obscurin Complexpossible reason for this (Fig. S1). We thus generated
shorter O17–99 and O17–103 constructs for crystalliza-
tion trials. Size-exclusion chromatography (SEC)
shows that all in vitro reconstituted complexes elute
earlier than the single components at a volume
corresponding to a calculated molecular mass of
about 20 kDa indicative of the formation of heterodi-
mers in solution (Fig. 1b). Crystals of M101–99:O17–99
and M101–99:O17–103 were obtained as described in
Materials and Methods. M101–99:O17–103 crystallizes
in the orthorhombic space groupP212121 with a single
heterodimer in the asymmetric unit (a.u.). These
crystals diffract to 1.95 Å resolution using synchrotron
radiation. M101–99:O17–99 crystals belong to the
trigonal space group P32212 and diffract to 3.30 Å
resolution with 18 heterodimers in the a.u. Data
processing and refinement statistics are shown in
Table 1.
The structure of the M10:O1 complex in both space
groups was solved by the molecular replacement
technique. The final models for the low-resolution
trigonal form and for the high-resolution orthorhombicFig. 2. M10:O1 complex. (a and b) Cartoon representation
top, respectively. M10 is shown in orange. O1 is shown in blu
conventional nomenclature for Ig domains [21]. (c) Enlarged
M10–O1 interactions. Color coding for carbon atoms is orange a
oxygen, red. Hydrogen bonds and salt bridges are dotted gree
structure of the M10 and O1 domains. The sequence and s
comparison. Amino acids are color coded according to seque
Colored circles show residues of one domain contacting the oform are characterized by R/Rfree values of 17.7%/
21.0% and 17.1%/21.0%, respectively. Electron
density is observed for residues M102–98:O17–100
and M102–98:O17–99 in the orthorhombic and trigonal
space groups, respectively. The lack of visible
electron density after residue Asp100 in the longer
O1 construct suggests C-terminal flexibility in agree-
ment with its tendency to natural proteolysis (Fig. S1).
Although diffraction data in the P32212 space group
extend only to 3.3 Å resolution, noncrystallographic
symmetry (NCS) averaging affords electron density
mapsof very good quality thanks to the presence of 18
copies of the complex in the a.u. (Fig. S2).
Overall architecture of the M10:O1 complex
The overall structure of the M10:O1 complex is
shown in Fig. 2a and b. Given the higher resolution of
the orthorhombic form, we will use this structure for the
general description of the complex. M10 and O1 Ig
domains are arranged head to tail with the N-terminal
portion of M10 interacting with the C-terminal region ofof the M10:O1 complex viewed from the front and from the
e. Secondary structural elements are labeled following the
view of the boxed region in panel a highlighting important
nd blue for M10 and OL1, respectively; nitrogen, dark blue;
n and red lines, respectively. (d) Sequence and secondary
econdary structure of the OL1 domain is also shown for
nce conservation as highlighted by the conservation bar.
ther as indicated in the inset.
Fig. 2 (legend on previous page)
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723Crystal Structure of the Titin:Obscurin ComplexO1, giving rise to a complex stabilized by parallel
intermolecular β-sheet augmentation. This architecture
was seen for the first time for the M10:OL1 complex
[17,18] and reflects the directionality of these filaments
in the muscle M-band [19]. Owing to the parallel
orientation of the long curvedβBandβGstrands inM10
and O1, respectively, the complex assumes a charac-
teristic chevron shape (Fig. 2a). Five main-chain
hydrogen bonds between residues V21, T23, and
A25 of M10 βB and residues I88, E90, and F92 of O1
βG hold the initial portion of these strands togetherFig. 3. Structure and topology of the M10 and O1 Ig-fold pro
(C1-set and C2-set), and intermediate (I-set) Ig-fold domains.
[20,21]. Strands are labeled according to the classical Ig-fold n
O1, respectively. The common orientation highlights the two Ig-
typical I-set topology, O1 displays a repositioning of its βA′ st
additional short α-helices (α1 and α2). Only the latter is prese
βAA′ linker, the βA′ strand, and the strand to which the latter H
cartoons. Letters N and C in panels b–d indicate the N- and C(Fig. 2c), thus establishing an extended mixed inter-
molecularβ-sheet contributedbyM10 (βA–βB–βE–βD)
and O1 (βG–βF–βC–βC′), respectively. Additional
H-bond interactions involve the M10 region connecting
βB to βA′, which binds to residues belonging to βC, βF,
and βG O1 strands. Salt bridges further hold the
complex together: the carboxylate groups of M10E8
and M10E56 interact with the guanidinium groups of
O1R15 and O1R11, respectively. Also, the side chain
M10K20 binds to the carboxylate of O1E90. Several
hydrophobic interactions also stabilize the M10:O1tomers. (a) Topology diagrams of variable (V-set), constant
The I-set combines features of both the V-set and C1-set
omenclature. (b and c) Cartoon representation of M10 and
fold β-sheets facing each other. While M10 conforms to the
rand. Strands are labeled as in panel a. M10 features two
nt in O1. (d) Superposition of M10 and O1 highlighting the
-bonds. Other parts of the Ig fold are shown as transparent
- termini, respectively.
724 Crystal Structure of the Titin:Obscurin Complexcomplex as seen in the residue interaction scheme in
Fig. 2d. Overall, the interface buries an area of about
1500 Å2.
The O1 domain is a deviant intermediate set
Ig-fold
The intermediate set (I-set) subfamily of the Ig-fold is
often found in muscle proteins [20]. This set was
identified by Harpaz and Chothia [21] as a separate
group distinct from the variable-like (V-set) and
constant-like (C1- and C2-set) Ig domains and
combining elements of both (Fig. 3a). Its topology
consists of a total of nine strands arranged into two
distinct β-sheets (βA–βB–βE–βD and βA′–βG–
βF–βC–βC′) folded into a β-sandwich. Like the V-set,
the I-set features a discontinuous first βA/βA′ strand
distributed over both β-sheets. The βA strand is initially
H-bonded to the βB strand in an antiparallel fashion
contributing to the βA–βB–βE–βD sheet. Following a
short break, it then crosses over to the other β-sheet
whereβA′hydrogenbonds to theβGstrand in aparallel
arrangement forming one edge of the βA′–βG–
βF–βC–βC′ sheet. The βA′ strand is not present
in C1- and C2-sets. Also, I-set domains, like V-set
domains, display conserved conformations for the links
joiningβA′andβBstrandsaswell asβEandβFstrandsFig. 4. The O1 βA′B loop displays alternative conformations
O1 domains from the M10:O1 complexes solved in the trigon
groups. The βA′B loop in the two structures (boxed area) is in a
the boxed area in panel a. Residues labeled in light and darker
and O1O, respectively.[21]. These loops are variable in C-sets. On the other
hand, like the C1-set, the I-set lacks the βC″ strand
typical of theV-set and features a very short βC′ strand.
M10 and O1 are structurally similar (Fig. 3b–d).
They display an rmsd of 1.71 Å for 90 aligned Cα
atoms.However,whereasM10 strictly conforms to the
classical I-set topology (Fig. 3b), O1 exhibits
a reorganization of its βA′ strand (Fig. 3c). This strand
does not pair with βG. Instead, it H-bonds to the
terminal portion of βB giving rise to a βA/βA′–
βB–βE–βD β-sheet. O1 thus exhibits a topology
somewhat reminiscent of the C1-set in which the
β-sandwich is contributed by two 4-stranded
(βA–βB–βE–βD and βG–βF–βC–βC′) β-sheets
(Fig. 3a). The βA′ repositioning seen in the ortho-
rhombic crystal form is also independently observed in
the trigonal space group (vide infra), indicating that
this is a genuine feature of the O1 Ig domain.
O1 flexibility
The availability of the M10:O1 structure in two
alternative crystal forms allows for a comparative
structural analysis. M10 domains in the trigonal
(M10T) and orthorhombic (M10O) space groups are
essentially identical. They display an rmsd of 0.57 Å
for 95 aligned Cα atoms. Similarly, low rmsd valuesin the crystal state. (a) Tube cartoon superposition of the
al (O1T, light blue) and orthorhombic (O1O, blue) space
different conformation. (b) Close-up stick representation of
blue highlight the different structure of the βA′B loop in O1T
Fig. 5 (legend on next page)
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726 Crystal Structure of the Titin:Obscurin Complexare also obtained when the alignment is performed
using the M10 domain solved in isolation [Protein
Data Bank (PDB) code 2Y9R] or the M10 domain
from M10:OL1 complexes solved in three alternative
space groups. Thus, the conventional I-set M10
domain is a rigid scaffold exhibiting very limited
structural variability. On the other hand, O1T and
O1O display a core rmsd of 1.08 Å for 92 aligned Cα
atoms. The region largely responsible for the higher
deviation is the loop region connecting the βA′ and βB
strands, which is in different conformations in the two
space groups (Fig. 4). This is quantified, for example,
by the intraloop distance between the Cα atoms of
O1S22 and O1D26. This distance is 7.85 Å and 12.3 Å
in O1T and O1O, respectively. Furthermore, DSSP
analysis [22] classifies the Ser8-Val20 region in O1T
as a long βA strand, thus enhancing the similarity of
this domain with the C1-set (Fig. 3b). A three-dimen-
sional alignment against the PDB database [23]
performed using the PDBeFold server [24] retrieved,
however, I-set Ig domains as the most structurally
similar to O1 with the Ig domain of human Aortic
Preferentially Expressed Protein-1 [25] being the
closest match (Q score = 0.79). Thus, O1 should be
considered an I-set Ig domain exhibiting an uncon-
ventional βA′ arrangement.
To seek an independent validation of the apparent
flexibility of the βA′–βB region in O1, we performed
molecular dynamics (MD) simulations. Three inde-
pendent replicas of 100-ns simulations were run for
isolated conventional I-set domains (M10 and OL1)
and O1. The time evolution of the root-mean-square
deviation (rmsd) from the starting equilibrated struc-
ture is shown in Fig. S3. The root-mean-square
fluctuation (rmsf) of the Cα coordinates from the
average structures, a measure of the structural
changes during the simulations, is given as
residue-based plot and as cartoon-sausage repre-
sentation in Fig. 5. While the conventional M10 and
OL1 I-set domains are remarkably stable, the O1
domain exhibits flexibility particularly for the βA′–βB
region (centred on residue 22), the βE–βF loopwhere
the short α1 helix is located (residue 74) and the
C-terminus. Thus, it appears that βA′ repositioning,
which results in the loss of the cluster of βA′–βG
hydrogen bonds typical of the conventional I-set,
enhances local flexibility.Fig. 5. MD simulations reveal an enhanced flexibility of O1 c
average structure for M10 (a), OL1 (b), O1O (c), and O1T (d
domain. The time evolution of the rmsd from the starting equilibr
rmsf representation of M10 (a′), OL1 (b′), O1O (c′), and O1T
flexibility defined as rmsf from the average position of Cα atom
for each domain. While the conventional M10 and OL1 I-set
flexibility for the βA′–βB region (*), the βE–βF loop where theHow frequent is the I-set βA′ repositioning
observed in O1?
The deviant I-set topology observed for O1 in the
M10:O1 complex led us to ask whether other known
I-set Ig structures display a similar βA′ repositioning.
We selected all proteins in the Pfam database [26]
annotated to contain one ormore I-set domains andwe
retrieved the corresponding structures from the PDB
[23]. We then performed a comparative structural
analysis (see Materials and Methods for details) to
identify I-set domains exhibiting a relocation of the βA′
hydrogen-bonding pattern from βG to βB indicative of
the switch. The bioinformatics analysis revealed that
this topological variation is uncommon. Of a total of 173
unique I-set Ig domains present in the PDB (filtering at
95% sequence identity), only 8 (including O1, 4.6%)
exhibit a relocation of their βA′ to the βA(/βA′)–
βB–βE–βD sheet (Fig. 6). For convenience, we refer
to these variants as the I*-set. Four I*-set domains are
found in the muscle protein myomesin. This protein
cross-links myosin filaments and has been suggested
to provide elasticity and to help maintain the overall
structural organization of the muscle fibers [27]. Its
C-terminal My9–My12 region (myomesin Ig domains
9–12) is composed of an array of virtually identical
I*-set structuralmodules followed by helical connectors
[27]. Functionally, the I*-set topology allows the
positioning of the C-terminal helices to generate a
superhelical arrangement while providing intramolecu-
lar stabilization. Three structurally similar I*-set do-
mains are also found in the Trk family of tyrosine
kinases receptors that bind ligand neutrophins, growth
factors critical to the functioning of the nervous system.
TrkA/B/C domain 5 (d5) structures both in the free state
[28] and in the neutrophins-bound form [29,30] feature
their βA′ bound to βB. Repositioning of the βA′ strand
helps in stabilizing the d5–neutrophins complex. Our
analysis also revealed that the fifth Ig domain of human
Kirrel3 (kin of irregular chiasm-like protein 3) solved
by NMR exhibits a very mobile βA′ strand exhibiting
limited interactions with either βG or βB. Thus,
Kirrel3-Ig5 can be considered somewhat in between
the I-set and I*-set. This domain is currently functionally
uncharacterized. Overall, our analysis suggests that
βA′ switch is evolutionarily rare. When present, it
typically mediates specific inter- or intramolecular
protein–protein interactions.ompared to conventional I-set domains. (a–d) rmsf from the
). Three replica simulations of 100-ns were run for each
ated structure is shown in Fig. S4. (a′–d′) Cartoon-sausage
(d′). The width of the tube is proportional to the degree of
s and calculated from the combination of the three replicas
domains are remarkably stable, the O1 domain exhibits
short α1 helix is located (**), and the C-terminus (C).
Fig. 6. The I*-set is a small subset of the I-set. Out of 173 structurally characterized unique I-set domains, 164 display
the conventional I-set topology (gray in the pie chart, 94.8%) while 8 (blue, 4.6%) exhibit a relocation of their βA′ such that it
is H-bonded to βB instead of βG. We defined this unconventional I-set as the I*-set. I*-set domains fall into three groups:
myomesin I*-set—an array of four structurally identical I*-set domains (My9, My10, My11, and My12) are found in
myomesin. My10 from PDB 2Y23 [27] is shown as an example. The Ig domain is shown in blue with its C-terminal helical
extension in yellow. The βA′–βB region is highlighted in red. The βA′ strand makes room and provides intramolecular
stabilization to the C-terminal helix; Trk I*-set—three I*-set domains are present in the Trk receptors (TrkA, TrkB, and
TrkC). The TrkB-d5 Ig domain (blue) in complex with neurotrophin-4/5 (yellow) from PDB 1WWW [30] is given as an
example. The relocated βA′ and the βA′–βB loop (red) strand stabilize the intermolecular interaction with the ligand;
obscurin I*-set—the O1 domain of obscurin was identified in this work as an I*-set. O1T and O1O (light and darker blue,
respectively) highlight alternative conformations of the βA′–βB loop (red); Kirrel3—the functionally uncharacterized fifth Ig
domain of Kirrel3 solved by NMR (PDB 2CRY) exhibits a βA′ strand with limited interactions with either βG or βB. Thus, it is
somewhat in between the I-set and the I*-set. The βA′ strand and βA′–βB loop region display together with the domain
termini the highest structural variability as shown by the cartoon tube representation. The average structure is shown as
rainbow gradient ranging from blue (lowest variability) to red (highest variability). Cα traces of the 20 individual NMR
models are also shown.
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Fig. 7. M10:O1 hinge rotation. (a and b) Orthogonal views of the M10:O1 complexes in the trigonal and orthorhombic
space groups superimposed using their M10 domains. M10 is shown in orange. O1 domains are color coded as in Fig. 4.
The O1 domains show a hinge rotation of approximately 15° about the βG strand. The latter is largely responsible for
establishing the molecular interface with M10 βB by β-strand augmentation. The chevron shape of the complex coupled
with βA′B loop plasticity results in a variable geometry for the open side as a result of the hinge rotation.
728 Crystal Structure of the Titin:Obscurin Complex
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The M10 domain is a scaffold exhibiting very
limited structural variability. The M10:O1 complexes
can thus be superposed with respect to their
rigid M10 common frame to highlight overall O1
displacements. Following M10T superposition to
M10O, O1T and O1O exhibit an rmsd of 3.05 Å for
their equivalent Cα atoms. This large displacement
results from a rotation about the βG strand “axis” ofFig. 8. M10:O1 and M10:OL1. (a) Cartoon superposition
figures, M10 and O1 are shown in orange and blue, respectiv
region of O1 and OL1 highlighting their orthogonal βA′ strands
(c) and M10:OL1 (d).more than 15° (Fig. 7). Such a “hinge” rotation leaves
the M10:O1 molecular interface, which is largely
directed by the H-bonding between O1 βG and M10
βB, unaffected, while altering the width of the open
side of the complex. For example, the Cα atoms of
Gly24, a very conserved βA′B loop residue in the
I-set [21], are displaced by 9.2 Å in the different
crystal forms (Fig. S4). The main reason for this
hinge rotation appears to be alternative crystal
packing. In the trigonal form, all 18 M10:O1of the M10:O1 and M1O:OL1 complexes. As in previous
ely. OL1 is in green. (b) Stick representation of the βA′B
. (c and d) Electrostatic surface representations of M10:O1
730 Crystal Structure of the Titin:Obscurin Complexcomplexes pack in a similar way with their “chev-
rons” wedged inside each other generating contin-
uous helices in the crystal (Fig. S5). On the other
hand, the packing arrangement in the orthorhombic
form leaves the open side of the chevron much more
solvent accessible (Fig. S6). From a functional
perspective, this observation indicates that weak
alternative crystal packing forces are able to capture
a degree of M10:O1 structural adaptability achieved
by coupling O1 βA′B loop plasticity to a hinge
rotation resulting in rather large variations for the
open side of the chevron-shaped complex.
Comparison between M10:O1 and M10:OL1
M10:O1 and M10:OL1 are very similar overall
(Fig. 8a). This was predicted on the basis of their
conserved interface residues (Fig. 2d), similar binding
affinities in the low micromolar range (Table 2), and a
virtually identical behavior in single-molecule for-
ce-extension experiments with both complexes yield-
ing at low forces around 30 pN [17]. Topological
differences between O1 and OL1 have nevertheless
implications for the fine structural properties of the
complexes. Like M10, OL1 folds in a conventional
I-set with its βA′ strand hydrogen bonded to βG. This
results in the βA′ strands of O1 andOL1 being roughly
orthogonal with respect to each other (Fig. 8a and b).
As a consequence, while alternateOL1 βA′ side chain
abut onto the open side of the chevron narrowing it,
the equivalent side chains in O1 βA′ point away from
the intermolecular space. Conversely, main-chain
atoms of the O1 Pro16-Val21 stretch face the open
side of the complex. Amino acid differences between
O1 andOL1 also contribute to alternative electrostatic
potentials in the two complexes (Fig. 8c and d).
Although residues at the molecular interface are
highly conserved, a striking difference is the re-
placement of OL1 F17 with an arginine residue (R15)Table 2. Isothermal titration calorimetry
Interaction N Kd (μM)
M10–O1 1.050 ± 0.005 2.70 ± 0.15
0.82 ± 0.03 5.08 ± 1.21
M10–OL1 1.040 ± 0.008 0.79 ± 0.09
1.07 ± 0.01 1.34 ± 0.16
M10–O1R15F 1.040 ± 0.003 0.41 ± 0.02
M10–OL1F17R 0.990 ± 0.014 1.28 ± 0.21
M10–O1A94Y — No binding
M10–OL1A96Y — No binding
M10A25K–O1 1.12 ± 0.04 11.01 ± 2.97
M10A25K–OL1 0.83 ± 0.04 2.16 ± 0.41
M10A25E–O1 0.87 ± 0.04 16.86 ± 3.47
M10A27E–OL1 0.91 ± 0.03 5.43 ± 0.98
M10D60R–O1 0.89 ± 0.04 15.20 ± 3.28
M10D60R–OL1 1.03 ± 0.01 4.39 ± 0.52
M10L61R–O1 0.89 ± 0.05 19.19 ± 4.75
M10L61R–OL1 1.19 ± 0.04 4.48 ± 1.28
Data in italics are from Ref. [17].in O1 (Fig. 2d). These residues map at the top of the
cavity defined by the chevron-shaped architecture
and are totally conserved within the vertebrate Obsl1
and obscurin families, respectively, effectively repre-
senting a signature of their Ig domains. Previous
isothermal titration calorimetry (ITC) measurements
(Table 2) and pull-down experiments have shown that
replacement of residue OL1 F17 with an arginine
residue (OL1F17R) diminishes the affinity of this
domain for M10 compared to wild-type OL1 [17].
Conversely, the R15F variation in O1 (O1R15F)
results in a higher affinity for M10 compared to both
wild-type O1 and OL1. However, the OL1F17R
mutation mimics O1 only partially as the X-ray
structure of the M10:OL1F17R complex shows that
OL1F17R retains the I-set topology. This suggests
that the I*-set is unlikely the product of a single
amino acid substitution and that it requires the
coevolution of residues on adjacent strands permis-
sive of such topological change.
The X-ray structure of the complexes suggests that
the interaction between M10 and its O1/OL1 binding
partners should be largely insensitive to the alternative
locations of βA′ strand as the latter is not directly
involved in the establishment of the molecular inter-
face. To test this, we generated M10A25K, M10A25E,
M10D60R, and M10L61R variants and tested their
binding to O1 and OL1 by ITC. Residues A25, D60,
and L61 are on the M10 surface and in the proximity of
O1/OL1. The M10 variants exhibited 1.6- to 4-fold
lower affinities compared to wtM10 (Table 2). Howev-
er, none of the mutants tested displayed a significant
differential affinity for its O1 or OL1 binding partner.
This further supports the notion that the binary M10:O1
andM10:OL1 interactions are essentially insensitive to
the topological difference between O1 and OL1.ΔH (kcal/mol) TΔS (kcal/mol) ΔG (kcal/mol)
11.16 ± 0.68 18.6 −7.4
6.31 ± 0.42 13.4 −7.1
3.87 ± 0.34 12.0 −8.1
3.70 ± 0.05 11.6 −7.9
5.64 ± 0.18 8.6 −7.9
0.66 ± 0.11 14.2 −8.6
— — —
— — —
0.48 ± 0.03 7.1 −6.6
4.10 ± 0.30 10.4 −6.3
3.98 ± 0.25 10.4 −6.4
3.56 ± 0.15 10.6 −7.1
2.15 ± 0.14 8.6 −6.5
2.83 ± 0.05 10.0 −7.2
1.64 ± 0.13 8.0 −6.3
0.25 ± 0.01 7.4 −7.2
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rat cardiomyocytes
Analysis of the M10:O1 and M10:OL1 structures
highlighted a limited number of residues whose
replacement would prevent complex formation. One
such position is occupied by A94 and A96 in O1 and
OL1, respectively (Fig. 9a). The methyl group of theFig. 9 (legend oside chain faces M10P11 and a large residue at this
position is not compatible with a stable complex. ITC
measurements confirmed that when O1A94 and
OL1A96 are replaced by a tyrosine residue, binding
is totally abolished (Table 2, Fig. 9b, and Fig. S7). To
validate the M10:O(L)1 interaction in the context
of the sarcomere, we tested O1A94Y and OL1A96Y
variants in a cellular competition assay andn next page)
732 Crystal Structure of the Titin:Obscurin Complexcompared their behavior to the wild-type domains.
When overexpressed in neonatal rat cardiomyo-
cytes (NRCs), GFP-O1 or GFP-OL1 targets the
sarcomeric M-band, in addition to other diffuse
subcellular localizations, displacing endogenous
obscurin (Fig. 9c and e) [2]. This is fully consistent
with a mutually exclusive binding of O1 and OL1 to
M10. Overexpression of GFP-O1A94Y and GFP-OL1-
A96Y in NRCs leads to a significant reduction of
displaced endogenous obscurin (Fig. 9d and f). This is
quantified in Fig. 9g. Both GFP-O1A94Y/GFP-O1A96Y
variants fail to displace obscurin above the level of
green fluorescent protein (GFP) control in agreement
with structural and biophysical (ITC) data. Importantly,
our quantitative analysis also shows that GFP-O1
competes endogenous obscurin better thanGFP-OL1
(p value = 0.0324) in spite of the slightly higher affinity
of OL1 for M10 compared to O1 (Table 2). One
possible explanation for this observation is that in the
NRCs, in addition to titin (M10), one ormore additional
binding partners are associated with the obscurin
domain O1 resulting in a complex of higher order than
the binary M10:O1 interaction. In this scenario, it is
reasonable that GFP-O1 is able to compete endog-
enous obscurin better than GFP-OL1 as the latter
domain can provide an optimal interface for M10 but
presumably not for other binding partners associated
with the M10:O1 complex. It is tempting to speculate
that architectural differences between M10:O1 and
M10:OL1 underpin their potential binding specificity at
the M-band.
Concluding remarks
The M-band C-terminus of titin binds the N-termi-
nus of obscurin at the myofibril periphery and the
N-terminus of Obsl1 at the myofibrillar inner core.
These interactions are mutually exclusive and are
directed by the M10 Ig domain of titin engaging either
the O1 Ig domain of obscurin or the OL1 Ig domain of
Obsl1. Currently, titin's M10, a frequent targetFig. 9. Biophysical and cellular validation in NRCs. (a) Close
representation in orange. O1 and OL1 are shown as tubes in b
OL1A96 are shown as sticks. A bulky residue at the O1A94/OL1
measurements confirm that the O1A94Y variant is unable to bind
is shown in the left-hand panel as reference. The OL1A96Y varia
Fig. S6). (c) Example of the competitive effect of overexpress
NRCs. The separate channels for endogenous myomesin, G
overlaid GFP mask for the outline of the transfected cell are
increased obscurin/myomesin ratio. (d) Similar to panel c for ov
to panel c for overexpressed GFP-fused OL1 (GFP-OL1). (f)
(GFP-OL1A96Y). (g) Quantification of endogenous obscurin dis
(n = 21), O1A94Y (n = 21), and OL1A96Y (n = 21). GFP al
displacement would be represented by a value of 1.0 on the y-a
and OL1 are able to compete endogenous obscurin. On the oth
GFP control levels in agreement with structural and biophysic
between O1 and O1A94Y (p b 0.0001), between OL1 and OL1
are statistically significant (****p ≤ 0.0001, ***p ≤ 0.001, **p ≤of disease-linkedmutations, is the only knownmuscle
Ig domain able to interact with two alternative ligands.
The M10:O1 and M10:OL1 share an identical
architecture with the two Ig domains arranged head
to tail, giving rise to a chevron-shaped complex
stabilized by parallel intermolecular β-sheet augmen-
tation. Unexpectedly, the O1 domain, differently from
both M10 and OL1, displays an evolutionarily rare
I-set variant topology, whereby the βA′ strand hydro-
gen-bonds to the terminal portion of βB instead of
exhibiting the typical switch to the βG–βF–βC–βC′
β-sheet. We identified this I-set variant as the I*-set. It
is tempting to speculate that such topological alter-
ation, which does not affect the direct interaction with
M10, might regulate the binding of alternative part-
ners. A few observations suggest that this hypothesis
warrants further investigations. The I-set topology is
generally very well conserved among cytoskeletal
proteins. We noticed that the few I*-set domains
characterized structurally and biochemically typically
employ their deviant βA′ strands to direct either
intermolecular (Trk) or intramolecular (myomesin)
interactions. Additionally, single-molecule force-
extension experiments show that both M10:O1 and
M10:OL1 complexes yield at forces around 30 pN [17].
This is indicates a very low mechanical stability when
compared, for example, to the Z-band telethonin–titin
complex, which requires around 800 pN to dissociate
[31]. Although the muscle M-band is more compliant
than the Z-disk [1], it is nevertheless surprising that
binary M10:O1 and M10:OL1 complexes possess
such a low mechanical stability. This could suggest
that additional factors are required to increase their
mechanical strength. Our assays in NRCs suggest
that additional elements of specificity might be
involved, possibly by ternary interactions of the M10:
O1complex, as the competition ofOL1 seems lower in
the cellular context. The O1 andOL1modules appear
perfectly poised as discriminatory structural elements
potentially involved in the binding of additional specific
partners.-up of the M10:O1/OL1 interface. M10 is shown as surface
lue and green, respectively. The side chains of O1A94 and
A96 position is incompatible with complex formation. (b) ITC
to M10 (right-hand panel). Data for the M10:O1 interaction
nt behaves in an identical manner as O1A94Y (Table 2 and
ed GFP-fused O1 (GFP-O1) on endogenous obscurin in
FP, endogenous obscurin, and the ratiometric image with
shown. The false-color scale range indicator shows an
erexpressed GFP-fused O1A94Y (GFP-O1A94Y). (e) Similar
Similar to panel c for overexpressed GFP-fused OL1A96Y
placed in NRCs expressing GFP-fused O1 (n = 21), OL1
one was also used as control (n = 6). Total obscurin
xis whereas 0.0 indicates absence of competition. Both O1
er hand, neither variant shows the ability to compete above
al (ITC) data. A two-tailed t test indicates that differences
A96Y (p = 0.0055), and between O1 and OL1 (p = 0.0324)
0.01, *p ≤ 0.05). Error bars are SEM values.
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Cloning and site-directed mutagenesis
DNA encoding for the last Ig domain of human titin
(residues 34352–34350, henceforth M10 1–99), the first Ig
domain of humanobscurin (O1, residues 1–109), and the first
Ig domain of human Obsl1 (OL1, residues 1–106) were
amplified by PCR with custom oligonucleotides primers
between the XhoI and BamHI restrictions sites of a in-house
modified pET9 vector. Downstream the His6-tag, this vector
encodes for a tobacco etch virus protease recognition.
Site-directed mutagenesis was performed using the Quik-
Change kit. All constructs were verified by sequencing.Protein expression and purification
All domains were expressed as N-terminal His6-tagged
fusion proteins in Rosetta 2(DE3) cells (Novagen). Trans-
formed cells were grown in Luria–Bertani medium
supplemented with 100 μg/ml ampicillin and 34 μg/ml
chloramphenicol at 37 °C until OD600 reached approximately
0.5. After decreasing the temperature to 18 °C, overnight
protein expression was induced with 0.15 mM IPTG. Cells
were harvested by centrifugation at 5000g for 15 min at 4 °C
and resuspended in phosphate-buffered saline (PBS) lysis
buffer in which NaCl concentration was increased to
250 mM. The cell suspension was supplemented with 2.4
U∕ml of benzonase (Novagen), 0.25 mg∕ml chicken egg
white lysozyme (Novagen), and Complete EDTA-free
protease inhibitor cocktail (Roche). Cell lysis was accom-
plished by two freeze-and-thaw cycles. Insoluble material
was sedimented by centrifugation at 16,500g for 1 h at 4 °C
and the supernatant was filtered using 0.22 μm prior to
loading on a His-trap HP column (GE Healthcare) preequili-
brated with the lysis buffer supplemented with 10 mM
imidazole. His6-tagged proteins were eluted with an imidaz-
ole linear gradient. Fractions containing the target His6-
tagged domains were collected and dialyzed overnight
against PBS buffer. During dialysis, the purification tag was
cleaved using tobacco etch virus protease. All cleavage
products bear a GSS amino acid triplet at the N-terminus
resulting from the cloning strategy. Uncleaved material was
removed from the mixture sample loading the dialyzed
protein solution on a His-trap HP column (GE Healthcare).
Untagged material was collected, concentrated, and further
purified bySECona16∕60HiLoadSuperdex75column (GE
Healthcare) equilibrated with 20 mM Hepes, pH 7.5, 50 mM
NaCl, and 1 mM DTT. M10, O1, OL1, and all variants
(M10A25K, M10A25E, M10D60R, M10L61R, O1A94Y, and
OL1A96Y) eluted from SEC as monomers. The M10:O1
complex used for crystallization was obtained mixing the
individual components with a 1∶1 molar ratio and allowing
incubation on ice for 30 min. The complex was further
purified by SEC as described above.
Crystal preparation
Crystallization trials were initially performed using M10:
O1(1–109) and M10:O1(7–109) complexes by the vapor
diffusion setup at 18 °C using a 1:1 protein:precipitant ratio
in 400-nl sitting drops dispensed with the aid of Mosquitocrystallization robot (TTP LabTech). These constructs
failed to yield crystals of good quality. Over time, we
observed proteolytic degradation of O1(7–109) leading to
a marginally smaller fragment. This observation was
further supported by limited proteolysis experiments.
Elastase and proteinase K digestion led to a O1(7–109)
truncation product virtually identical with that of the aged
sample (Fig. S1). This led us to engineer O1 domains with
marginally shorter C-termini. The crystallization of M10:
O1(7–99) was pursued by both vapor diffusion and batch
techniques. Batch crystallization screening performed at
the Hauptman–Woodward Medical Research Institute
(Buffalo, NY) produced initial hits that were judged more
promising than those obtained by vapor diffusion methods.
Crystallization conditions were further refined in-house
using the batch setup. Crystals of M10:O1(7–99) belong-
ing to space group P3221 were obtained using 0.1 M
trisodium citrate, pH 3.6, and 3.0 M sodium chloride as
precipitant. Crystals of M10:O1(7–103) belonging to space
group P212121 were obtained by the hanging drop method
using 0.1 M Tris–HCl, pH 8.5, 0.2 M sodium acetate,
and 30% polyethylene glycol 4000 as precipitant. Cryo-
protection was performed in reservoir supplemented with
20% (v/v) ethylene glycol.Data collection, structure solution, and crystallographic
refinement
M101–99:O17–103 crystallizes in the orthorhombic space
group P212121 with a single heterodimer in the a.u. These
crystals diffract to 1.95 Å resolution using synchrotron
radiation (Table 1). M101–99:O17–99 crystals display a
rod-shaped morphology with typical cross-dimensions of
about 30 Å. They diffract X-rays rather poorly using
synchrotron radiation and are radiation damage sensitive.
An initial complete data set was collected at the I04 beamline
(Diamond Light Source) at the 3.5-Å resolution. Matthews
coefficient analysis in most probable 321 point group
symmetry suggested a high number of molecules in the
a.u. In consideration of the low diffracting power of these
crystals, we believed the number of M10:O1 complexes in
the a.u. to be between 13 (70% solvent content) and 22 (50%
solvent content). A strong (0.000, 0.000, 0.424) peak in the
nativePattersonmapcorresponding toapproximately 40%of
the origin peak indicated the presence of translational NCS
along the screw 3-fold axis. A molecular replacement search
using theprogramMOLREP [32] anda template derived from
the M10:OL1 complex identified 14 copies of the complex.
However, voids in the packing arrangement suggested
the presence of additional complexes. Later, a second data
setwasmeasuredat the3.3-Å resolution (Table 1) employing
a wedged helical collection strategy at the microfocus I24
beamline (Diamond Light Source) and used for further
crystallographic refinement. The high Rmerge statistics for
this data set (21.5% overall, Table 1) is most likely related to
its low 〈I/σ(I)〉 value as seen in other similar PDB depositions
(e.g., 4PBA [33]). Improved electron density maps allowed
manual positioning of four additional heterodimers. Overall,
the completemodel in the trigonal space group comprises 18
M10:O1 complexes corresponding to a 59% solvent content.
Dramatic differences in crystal quality between M101–99:
O17–103 andM101–99:O17–99 highlight the critical importance
of subtle variations in construct design. Refinement of the
complex in both space groups was carried out with
734 Crystal Structure of the Titin:Obscurin ComplexREFMAC5 [34] and BUSTER [35] using NCS restraints for
the low-resolution data set. Data collection and refinement
statistics are shown in Table 1.
Isothermal titration calorimetry
Samples for ITC measurements were extensively
dialyzed in ITC buffer [20 mM Tris–HCl, pH 7.5, 50 mM
NaCl, and 1 mM tris(2-carboxyethyl)phosphine–HCl]. ITC
experiments were conducted on a MicroCal ITC (MicroCal
Inc.) instrument at a temperature of 20 °C. Data were
corrected for heats of dilution of the protein solution.
Binding constants and other thermodynamic parameters
were calculated by fitting the integrated titration data
assuming a single set of binding sites using the Origin
software package (OriginLab, Northampton, MA).Bioinformatics analysis
A list of the known protein structures containing an I-set
domain was derived from the Pfam database [26] entry
PF07679. For each structure, the region encompassing the
I-set domain was extracted from the corresponding PDB file
and aligned with the O1 structure using TM-align [36]. The
H-bonding pattern of the βA′ strand with the adjacent strands
was detected using DSSP [22]. I-set Ig domains were
classified as “conventional” if the βA′ was H-bonded to βG.
They were classified as “I*” if βA′ was H-bonded to βB.
MD simulations
MD simulations of M10, OL1, and the two crystallographic
forms ofO1were performedwithGROMACS4.6.2 [37] using
the ff-amber99sb-ILDN [38] porting of the AMBER parm99
parameter set. The initial structures were solvated with a
cubic box of TIP3Pwatermolecules. Ionizable residueswere
modeled in their standard protonation state at pH 7.0. The
systems were then neutralized adding the appropriate
number of counterions. System equilibration and thermaliza-
tion was performed as previously described [39]. Production
simulations were performed in the NPT ensemble and
periodic boundary conditions were imposed. All the bonds
were frozen and a 2-fs time step was used. Electrostatic
interactions were calculated with the particle mesh Ewald
method with a 14-Å cutoff for the direct space sums, a 1.2-Å
fast Fourier transform grid spacing, and a four-order
interpolation polynomial for the reciprocal space sums. For
van der Waals interactions, a 14-Å cutoff was used. The
neighbor list for noncovalent interactions was updated every
five steps. Three replicas of 100-ns simulations were
generated for each system.
Cellular competition assays in NRCs and ratiometric
analysis
NRC isolation, culture, transfection, and staining were
performed essentially as described previously [17]. Briefly,
NRCs were transfected with GFP-tagged transiently ex-
pressing constructs (pEGFPC2-, Clontech) using Escort III
(Sigma Aldrich). After 48 h culture to promote protein
expression, cells were fixed with 4% paraformaldehyde/
PBS, permeabilized with 0.1% Triton X-100/PBS, and thenstained with the appropriate antibodies. The antibodies used
for the current work were as follows: MyB4, a mouse
monoclonal antibody to the myomesin domain My12 [40];
and Ob5859, a rabbit polyclonal antibody to two consecutive
Ig domains in obscurin, Ob58 and Ob59 [41,42]. All
fluorescent-conjugated secondary antibodies were pur-
chased from Jackson ImmunoResearch (USA). All images
for ratiometry analysis were collected by a Zeiss LSM510
confocal microscope basically as described previously [2].
To see the competitive effect of overexpressed GFP-O1 or
GFP-OL1 and their variants on endogenous obscurin, we
imported 16-bit-per-channel RGB files into Mathematica 10
and translated them to ensure correct alignment of the
myomesin and obscurin channels. Background subtraction
was performed on these channels by subtracting a 50-pixel
radius Gaussian filtered version of that channel. The
arctangent of the obscurin and myomesin intensities was
then calculated on a pixel-by-pixel basis to give a ratio image
of obscurin to myomesin that was linearly scaled between 0
and 1. A value of 0 corresponded to no obscurin in the
presence of myomesin, while a value of 1 corresponded to
obscurin in the absence of myomesin. A value of 0.5
corresponded to equal intensities in both channels. The
GFP channel was binarized to create a segmented image
corresponding to GFP-positive and GFP-negative regions.
The ratio image was multiplied by this mask and separately
with an inverted version of this mask to give two ratio images
that corresponded to the GFP-positive and GFP-negative
regions of the image as two separate images. A histogram for
each imagewas then determined and normalized to a total of
1 for each histogram. Plotting these against each other thus
allowed comparison in shifts in ratio. A left shift (towards zero)
indicated a reduction of obscurin in the GFP-positive ratio
image. The difference between the two curves in this
direction was calculated and the data presented represent
one minus the total integrated difference between these two;
thus, a value of 1 here represented total competition of the
GFP fusion for endogenous obscurin, while a value of 0
represented no competition.
Accession numbers
Coordinates and structure factors have been deposited
in the PDB with accession numbers 4UOW and 4C4K.Acknowledgments
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